Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
出版年份 2020 全文链接
标题
Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 9, Issue 5, Pages 1398
出版商
MDPI AG
发表日期
2020-05-12
DOI
10.3390/jcm9051398
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
- (2020) Ole-Christian W Rutherford et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice
- (2020) Michael Fralick et al. ANNALS OF INTERNAL MEDICINE
- Restarting of anticoagulation in patients with atrial fibrillation after major bleeding: A meta‐analysis
- (2020) Ying Zhou et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Novel antithrombotic effects of dabigatran in patients with non-valvular atrial fibrillation
- (2020) Keisuke Tsuda et al. THROMBOSIS RESEARCH
- Comparative stroke, bleeding, and mortality risks in older Medicare patients treated with oral anticoagulants for nonvalvular atrial fibrillation
- (2019) David J. Graham et al. AMERICAN JOURNAL OF MEDICINE
- Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: A network meta-analysis
- (2019) Christina Antza et al. SCANDINAVIAN CARDIOVASCULAR JOURNAL
- The Spectrum of Small Intestinal Lesions in Patients with Unexplained Iron Deficiency Anemia Detected by Video Capsule Endoscopy
- (2019) Antonella Contaldo et al. Medicina-Lithuania
- Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial
- (2019) Jeffrey B. Washam et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance
- (2019) Hiroshi Inoue et al. Journal of Cardiology
- Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial
- (2019) Aiman Alak et al. EUROPACE
- Effectiveness and Safety of Four Direct Oral Anticoagulants in Asians with Non-valvular Atrial Fibrillation
- (2019) Yi-Hsin Chan et al. CHEST
- Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis
- (2019) Ichiro Sakuma et al. HEART AND VESSELS
- Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies
- (2019) Anneka Mitchell et al. Journal of Clinical Medicine
- Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation
- (2019) Manon C. Stam-Slob et al. CIRCULATION
- Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation
- (2019) Gregory Y.H. Lip et al. CIRCULATION
- Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight
- (2019) Stefan H. Hohnloser et al. CIRCULATION
- Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis
- (2019) Zhi-Chun Gu et al. Clinical Gastroenterology and Hepatology
- Patient characteristics and stroke and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban and vitamin K antagonists: a Spanish real-world study
- (2019) Sreeram V Ramagopalan et al. Journal of Comparative Effectiveness Research
- Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users
- (2019) Carlos Sostres et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Real‐World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
- (2019) Shin‐Yi Lin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study
- (2019) Lars J. Kjerpeseth et al. PLoS One
- Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry
- (2019) Miney Paquette et al. AMERICAN JOURNAL OF CARDIOLOGY
- Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group
- (2019) Alan N. Barkun et al. ANNALS OF INTERNAL MEDICINE
- International Consensus Guidelines for Nonvariceal Gastrointestinal Bleeding: A Step Forward
- (2019) Angel Lanas ANNALS OF INTERNAL MEDICINE
- Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
- (2019) Laurent Fauchier et al. EUROPACE
- Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
- (2019) Moon et al. Journal of Clinical Medicine
- Oral Anticoagulant Therapy—When Art Meets Science
- (2019) Patricia Lorena Cîmpan et al. Journal of Clinical Medicine
- Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post–PCI in Patients With Atrial Fibrillation and Diabetes
- (2019) Michael Maeng et al. JACC-Cardiovascular Interventions
- Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
- (2019) M. Jansson et al. THROMBOSIS RESEARCH
- Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
- (2019) Jiesuck Park et al. Journal of Clinical Medicine
- Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants
- (2018) Mark M. Brodie et al. AMERICAN JOURNAL OF MEDICINE
- Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran
- (2018) Jennifer M. Kolb et al. DIGESTIVE DISEASES AND SCIENCES
- Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS
- (2018) A John Camm et al. EUROPACE
- Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
- (2018) Guowei Li et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018
- (2018) Joseph JY Sung et al. GUT
- Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
- (2018) Niklas W. Andersson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
- (2018) Yana Vinogradova et al. BMJ-British Medical Journal
- Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
- (2018) Yana Vinogradova et al. BMJ-British Medical Journal
- Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
- (2018) Brandon K. Martinez et al. Journal of the American Heart Association
- Non-variceal upper gastrointestinal bleeding
- (2018) Angel Lanas et al. Nature Reviews Disease Primers
- Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review
- (2018) Jean-Baptiste Briere et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
- (2018) Karen P. Alexander et al. AMERICAN HEART JOURNAL
- Apixaban Levels in Octogenarian Patients with Non-valvular Atrial Fibrillation
- (2018) Ran Nissan et al. DRUGS & AGING
- Persistence on apixaban in atrial fibrillation patients
- (2018) Paolo Verdecchia et al. Journal of Cardiovascular Medicine
- Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
- (2017) Tomas Forslund et al. EUROPACE
- Risk of gastrointestinal bleeding during anticoagulant treatment
- (2017) Aitor Lanas-Gimeno et al. Expert Opinion On Drug Safety
- Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study
- (2017) Neena S. Abraham et al. GASTROENTEROLOGY
- Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study
- (2017) Vilhelm Sjögren et al. PLoS One
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
- (2017) Myung-Jin Cha et al. STROKE
- Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
- (2017) Ka-Shing Cheung et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2017) Peter Brønnum Nielsen et al. BMJ-British Medical Journal
- Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2017) Peter Brønnum Nielsen et al. BMJ-British Medical Journal
- Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
- (2017) Gboyega Adeboyeje et al. Journal of Managed Care & Specialty Pharmacy
- Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
- (2016) Peter A. Noseworthy et al. CHEST
- A Comparison of Dabigatran With Warfarin for Stroke Prevention in Atrial Fibrillation in an Asian Population
- (2016) Lok Bin Yap et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real-world” observational study in the United States
- (2016) Gregory Y. H. Lip et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants
- (2015) Ángel Lanas et al. Clinical Gastroenterology and Hepatology
- Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study
- (2015) H.-Y. Chang et al. BMJ-British Medical Journal
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study
- (2015) H.-Y. Chang et al. BMJ-British Medical Journal
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
- (2013) I. Lisanne Holster et al. GASTROENTEROLOGY
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies
- (2013) Jay Desai et al. THROMBOSIS AND HAEMOSTASIS
- Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
- (2010) Isla M. Ogilvie et al. AMERICAN JOURNAL OF MEDICINE
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
- (2009) S. SCHULMAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation